Related Experiment Video
Updated: Mar 24, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Vaccinations for rheumatoid arthritis
Marcia A Friedman1, Kevin Winthrop
1aDepartment of Rheumatology bDepartment of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA.
Vaccinations are crucial for rheumatoid arthritis (RA) patients, but drug therapies can impact effectiveness. This review guides optimal vaccine use and timing for RA care.
Area of Science:
- Rheumatology
- Immunology
- Infectious Diseases
Background:
- Rheumatoid arthritis (RA) patients face higher risks of infectious diseases.
- Disease-modifying antirheumatic drug (DMARD) therapy can affect vaccine immunogenicity.
- Vaccine selection and timing are critical considerations in RA management.
Purpose of the Study:
- To review current indications for vaccines in RA patients.
- To assess the safety and immunogenicity of vaccines in RA.
- To provide guidance on optimal vaccine use and timing for rheumatologists.
Main Methods:
- Literature review of recent recommendations and studies.
- Analysis of vaccine indications, safety, and immunogenicity data.
- Synthesis of evidence regarding vaccine effectiveness in RA patients on DMARDs.
Main Results:
- Influenza, pneumococcal, and shingles vaccines are recommended for RA patients.
- These vaccines are generally safe and immunogenic, except with rituximab therapy.
- Hepatitis B and HPV vaccines are also well-tolerated and immunogenic.
- Live vaccines (shingles, yellow fever) may be safe in select RA patients.
Conclusions:
- Optimal use and timing of routine vaccinations are essential for RA patient care.
- This review provides updated guidance for rheumatologists.
- Vaccination strategies should be tailored to individual RA patient needs and therapies.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Vaccinations
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

